C
PCVX icon

Covestor’s Vaxcyte PCVX Stock Holding History

Covestor’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42K Buy
716
+531
+287% +$28.8K 0.02% 885
2026
Q1 		$11K Sell
185
-154
-45% -$8.36K 0.01% 1354
2025
Q4 		$16K Hold
339
– – 0.01% 1374
2025
Q3 		$12K Sell
339
-1
-0.3% -$33 0.01% 1505
2025
Q2 		$11K Sell
340
-704
-67% -$23.1K 0.01% 1546
2025
Q1 		$39K Buy
1,044
+329
+46% +$26.3K 0.03% 937
2024
Q4 		$59K Sell
715
-342
-32% -$34K 0.04% 785
2024
Q3 		$121K Sell
1,057
-96
-8% -$8.65K 0.08% 411
2024
Q2 		$87K Hold
1,153
– – 0.06% 586
2024
Q1 		$79K Buy
1,153
+944
+452% +$65.4K 0.05% 675
2023
Q4 		$13K Hold
209
– – 0.01% 1392
2023
Q3 		$11K Buy
209
+204
+4,080% +$10.1K 0.01% 1384
2023
Q2 		$0 Sell
5
-1
-17% -$47 ﹤0.01% 2507
2023
Q1 		$0 Sell
6
-9
-60% -$382 ﹤0.01% 2433
2022
Q4 		$1K Buy
15
+6
+67% +$235 ﹤0.01% 1914
2022
Q3 		$0 Sell
9
-1
-10% -$25 ﹤0.01% 2423
2022
Q2 		$0 Sell
10
-3
-23% -$69 ﹤0.01% 2237
2022
Q1 		$0 Sell
13
-4
-24% -$87 ﹤0.01% 2346
2021
Q4 		$0 Buy
+17
New +$395 ﹤0.01% 2247

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Covestor's PCVX Position: Q2 2026 in Review

Covestor increased its Vaxcyte (PCVX) stake by 287% in Q2 2026, buying an estimated $28.8K and bringing the position to 716 shares worth $42K. The position accounts for 0.02% of the portfolio, ranked #885.

Covestor first reported a position in PCVX in Q4 2021 and has held it in 19 quarters since. The position peaked at $121K in Q3 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Covestor held 716 shares of Vaxcyte worth $42K as of Q2 2026.
  • Covestor bought 531 Vaxcyte shares in Q2 2026, an estimated $28.8K.
  • Vaxcyte made up 0.02% of Covestor's portfolio in Q2 2026, its #885 holding.
  • Covestor first reported a position in Vaxcyte in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Vaxcyte position peaked at $121K in Q3 2024.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.